Cargando…
A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial
BACKGROUND: Uterine fibroids are the most common tumour in women of reproductive age. By the time they are 50-years-old around 80% of women will have developed one. Of these, around half will experience symptoms which will impact negatively on their quality of life. Hysterectomy is the traditional t...
Autores principales: | McPherson, Klim, Manyonda, Isaac, Lumsden, Mary-Ann, Belli, Anna-Maria, Moss, Jon, Wu, Olivia, Middleton, Lee, Daniels, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258053/ https://www.ncbi.nlm.nih.gov/pubmed/25432688 http://dx.doi.org/10.1186/1745-6215-15-468 |
Ejemplares similares
-
Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial
por: Sirkeci, Fusun, et al.
Publicado: (2023) -
Uterine artery embolization or myomectomy for women with uterine fibroids: Four-year follow-up of a randomised controlled trial
por: Daniels, Jane, et al.
Publicado: (2021) -
Randomised Controlled Trial of Particles Used in Uterine fibRoid Embolisation (PURE): Non-Spherical Polyvinyl Alcohol Versus Calibrated Microspheres
por: Das, Raj, et al.
Publicado: (2022) -
Treating symptomatic uterine fibroids with myomectomy: current practice and views of UK consultants
por: Sirkeci, R. Fusun, et al.
Publicado: (2017) -
Randomised trial of two embolic agents for uterine artery embolisation for fibroids: Gelfoam versus Embospheres (RAGE trial)
por: Yadavali, R., et al.
Publicado: (2019)